EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Nutex Health Inc. (NUTX) had EBITDA of $77.30M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$211.79M
Net Income	$14.63M
Cost of Goods Sold	$93.45M
Gross Profit	$118.34M
Operating Expenses	$139.58M
Operating Income	$72.21M
Non-Operating Income/Expense	$-9.45M
Pre-Tax Income	$62.76M
Normalized Pre-Tax Income	$62.76M
Income after Taxes	$44.22M
Income from Continuous Operations	$44.22M
Consolidated Net Income/Loss	$44.22M
Normalized Income after Taxes	$44.22M
EBIT	$72.21M
EBITDA	$77.30M
Weighted-Average Shares Outstanding (Basic)	5.52M
Weighted-Average Shares Outstanding (Diluted)	5.52M
Earnings per Share (EPS) (Basic)	$2.65
Earnings per Share (EPS) (Diluted)	$2.56
Balance Sheet Financials
Current Assets	$401.52M
Property, Plant, and Equipment	$76.43M
Long-Term Assets	$360.40M
Total Assets	$761.92M
Current Liabilities	$176.57M
Long-Term Debt	$280.12M
Long-Term Liabilities	$310.47M
Total Liabilities	$487.04M
Common Equity	$274.88M
Tangible Shareholders Equity	$245.76M
Shareholders Equity	$274.88M
Common Shares Outstanding	5.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$50.97M
Cash Flow from Investing Activities	$-0.06M
Cash Flow from Financial Activities	$-6.81M
Beginning Cash	$43.58M
End Cash	$87.67M
Increase/Decrease in Cash	$44.09M
Stock-Based Compensation	$36.09M
Common Stock Dividends Paid	$-7.36M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.50
Debt to Equity Ratio	1.12
Gross Margin	55.88%
Operating Margin	34.09%
EBIT Margin	34.09%
EBITDA Margin	--
Pre-Tax Profit Margin	29.64%
Profit Margin	6.91%
Free Cash Flow	$50.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.28
Inventory Turnover	29.97
Receiveable Turnover	0.71
Days Sales in Receivables	127.20
Return on Equity	16.09%
Return on Tangible Equity	17.99%
Return on Assets	5.80%
Return on Investments	7.97%
Book Value Per Share	$49.73
Free Cash Flow per Share	$9.23
Operating Cash Flow per Share	$9.24

Data from Zacks Investment Research, Inc.